Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.11.10.566600

Stress-induced endogenous-dsRNAs drive beta-cells to IFN-I state

Abstract

Aims/hypothesisEndogenous dsRNAs originating from retrotransposons within the human genome have the potential to trigger autoimmunogenic recognition via RIG-like receptors such as MDA5. This phenomenon, known as "viral mimicry", induces potent interferon-beta expression, resulting in cell death and potential collateral death to surrounding cells. Viral mimicry has been mostly studied in relation to epigenetic therapeutics, although there are indications the phenomenon is relevant in other physiological contexts. Here, we demonstrate that proinflammatory cytokine stress leads to the dysregulation of retrotransposons in human beta-cells, resulting in beta-cell death via viral mimicry. MethodsHuman islets from donors were treated with/without proinflammatory cytokines (IFN-{gamma}, TNF-, IL-1{beta}) and immunostained for dsRNA. Publicly available transcriptome and chromatin accessibility data from proinflammatory cytokine treated EndoC-{beta}H1 cells were analyzed to examine changes in transcriptional regulatory activity at retrotransposon loci. Transcriptome profiling experiments in 1.1B4 and MIN6 cells were performed to examine the generality of the results. Adenosine to inosine (A-to-I) editing was compared between sample groups to gauge the extent of RNA editing on dsRNAs. Additional transcriptome data from normal vs. type 1 diabetic human islets was also assessed for differences in A-to-I editing activity between sample groups. ResultsProinflammatory cytokine stress increases the amount of dsRNA in human islets, co-incident with cells that express insulin. In the EndoC-{beta}H1 human beta-cell line, proinflammatory cytokine stress leads to a substantial increase in transcription at RTE loci, including SINE/Alu elements and LINE elements, along with increased expression of RLRs (including MDA5), inflammatory transcription factors (e.g. IRF3, STAT1), and most critically, IFNB1, a potent instigator of type 1 interferon responses. Similar trends were observed in 1.1B4 and MIN6 cells. Gene ontology analysis revealed an enrichment of genes related to interferon signaling and inflammation. Inflammatory stress furthermore leads to an increase in chromatin accessibility at many RTE loci, with enrichment in a variety of RTE subfamilies (including L1, AluY, AluSp, AluSq2, and AluSc elements). Binding sites for inflammatory transcription factors, such as IRFs, are also enriched at these loci. While inflammatory stress increased the overall A-to-I editing events at Alu elements, the pool of total unedited Alus was increased upon inflammatory stress. Examination of A-to-I editing in RNA-seq data from type 1 diabetic human islets and normal controls revealed that editing in diabetic islets is dramatically lower ([~]1%) than islets from normal controls ([~]15%). Conclusions/interpretationTranscription and chromatin accessibility are both increased at RTEs (notably Alus) upon proinflammatory cytokine stress, accompanied by an increase in RLR expression and a shift to a type I interferon state, as indicated by increased IFNB1 and other interferon-stimulated genes, including MDA5, an RLR gene which is also a type 1 diabetes risk gene. The overall increase in A-to-I editing upon inflammatory stress is associated with increases in ADAR1 expression, yet the increase in overall unedited Alus shows that cytokine stress leads to a higher dsRNA burden in the beta-cell. This increase in dsRNA burden is further compounded by increased MDA5 expression, exacerbating the inflammatory state of the beta-cell. Comparisons of A-to-I editing between normal vs. type 1 diabetic human islets suggest that type 1 diabetics have more unedited dsRNAs, hindering their ability to prevent autoimmunogenic recognition. Research in contextWhat is already known about this subject? O_LICytokine stress during insulitis is a feature of autoimmune diabetes. C_LIO_LIStress-induced dysregulation of retrotransposons can lead to a dsRNA-based type-I interferon response in a variety of cells ( viral mimicry) C_LIO_LIEndogenous dsRNAs are subject to adenine to inosine (A-to-I) editing by ADAR1 to prevent self-recognition. C_LI What is the key question? O_LICan cytokine stress drive beta-cells into an IFN-I state via recognition of endogenous dsRNAs derived from retrotransposons that lose silencing under cytokine stress? C_LI What are the new findings? O_LICytokine stress causes an increase in dsRNAs derived from retrotransposons in beta-cells from human islets. C_LIO_LIThe SINE/Alu subset of these endogenous dsRNAs are less edited in stressed beta-cells, making them more self-recognizable. C_LIO_LIType 1 diabetic human islets exhibit more unedited Alus. C_LI How might this impact on clinical practice in the foreseeable future? O_LIInnate autoimmunity via endogenous dsRNAs can cause damage to beta-cells; therapies to target this pathway may help treat autoimmune diabetes. C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Chi, K. K., Senapati, P., Leung, A., Schones, D.. 2023-11-10. Stress-induced endogenous-dsRNAs drive beta-cells to IFN-I state. https://doi.org/10.1101/2023.11.10.566600

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Simvastatin and Primaquine Identified as Potential Endometriosis Therapeutics via a Novel Epithelial-Stromal Assembloid Drug Screening Assay

Background: Endometriosis is an estrogen-driven, inflammatory disorder affecting ~10% of menstruators, causing severe pain. Current treatments that reduce estrogen or inflammation have inconsistent efficacy and poor tolerability. Therapies identified via drug-repositioning methods, which target patient-specific pathways, offer a promising alternative. Simvastatin and primaquine were identified as potential treatments, strongly reversing endometriosis-associated gene expression pathways, and behavioral testing in an animal model showed that these drugs diminish endometriosis-associated pain. This paper examines their effects in human assembloids to provide proof-of-concept validation and insights into their mechanisms of action relevant to endometriosis. Methods: We established human endometrial assembloids using immortalized epithelial (12Z) and stromal fibroblast (iEc) cell lines, as well as primary tissue from patients. Assembloids were generated in 96-well agarose molds with both cell types. We tested ibuprofen, fenoprofen, primaquine, and simvastatin. Following a 24-hour exposure, assembloids and monolayer cultures were harvested and stranded mRNA-seq libraries were sequenced on an Illumina NovaSeqX Plus System. Results: Gene set enrichment analysis showed key pathway reversals: Primaquine reversed the chemical carcinogenesis ROS pathway in assembloids. Simvastatin reversed cytokine-cytokine receptor interaction in both epithelial and stromal cell lines, and the cytoskeleton in muscle cells pathway in stromal cell lines. Fenoprofen reversed the calcium signaling pathway in stromal cell lines. Conclusion: Simvastatin induced the most significant gene expression changes, notably reversing cytokine-cytokine receptor interactions in both cell lines, mirroring findings from our rat model. Despite the small sample size limitation, these experiments highlight the promise of assembloid models to test therapeutic candidates for endometriosis.

molecular biology↗

A feed-forward UHRF1 read-write mechanism supports H3 multi- mono-ubiquitination and DNA methylation maintenance at CpG-sparse regions

The epigenetic inheritance of mammalian DNA methylation requires DNMT1 and its E3 ligase cofactor UHRF1. At newly replicated chromatin, UHRF1 recognition of hemi-methylated DNA and histone H3 N-terminal tails directs catalysis of H3K14, H3K18, and/or H3K23 mono-ubiquitination to recruit DNMT1. While it is appreciated that UHRF1 can deposit multiple mono-ubiquitin marks on a single H3 tail and that DNMT1 recognizes this state through tandem ubiquitin interacting motifs, the mechanism that promotes successive ubiquitination and the biological function of multi-mono-ubiquitination are unknown. Here, we show that UHRF1 directly binds its mono-ubiquitinated H3 products through a previously uncharacterized LGDDSL loop in Tudor 2 of its tandem Tudor domain (TTD) to promote further ubiquitin deposition. Disruption of this ubiquitin reading activity impairs H3 multi-mono-ubiquitination and accelerates DNA methylation loss within late-replicating, CpG-sparse genomic regions that are characteristic of partially methylated domains (PMDs) in cancer and aging cells. These methylation defects overlap those observed by disruption of UHRF1 ubiquitin ligase activity, providing convergent evidence that both writing and reading of H3 ubiquitination support CpG-sparse DNA methylation maintenance. Together, these findings establish a feed-forward ubiquitin read-write mechanism that generates multi-mono-ubiquitinated H3 and safeguards DNMT1-dependent DNA methylation maintenance at vulnerable genomic regions of the mammalian methylome.

molecular biology↗

Calcium dysregulation amplifies fibrotic responses to TGFβ in human Friedreich's ataxia fibroblasts

Friedreich's ataxia (FA) is an inherited disease caused by loss of frataxin (FXN) and characterized by neurodegeneration and fatal cardiomyopathy. Cardiac fibrosis contributes to cardiomyopathy by stiffening the heart wall, yet the underlying mechanisms remain unknown. Here, we investigated pro-fibrotic predisposition in FA patient-derived fibroblasts, focusing on the role of cytosolic calcium (Ca) in TGF{beta}-driven fibroblast-to-myofibroblast transition (FMT). We found pro-fibrotic transcriptional priming in FA fibroblasts, alongside elevated expression of genes controlled by the Ca-responsive transcription factor NFAT. Upon FMT, FA myofibroblasts showed amplified induction of pro-fibrotic (CCN2, NOX4) and suppression of anti-fibrotic (CCN3) genes, which were inversely correlated with residual FXN. Mechanistically, FA fibroblasts exhibited elevated cytosolic Ca and strongly downregulated expression of the Na-Ca exchanger NCX1, which directly correlated with FXN. Furthermore, NCX1 inhibition in control fibroblasts recapitulated FA Ca phenotypes, whereas NCX1 transduction in FA fibroblasts normalized Ca dynamics and blunted CCN2 induction in FMT. These findings highlight NCX1 as a modulator of fibrotic reprogramming in FA and identify Ca dyshomeostasis as an intrinsic mechanism of fibrosis that could be targeted therapeutically.

molecular biology↗